
Final overall survival data for PEACE-3 (NCT02194842) evaluating the combination of enzalutamide (Xtandi) and radium-223 (Xofigo) will be presented at the 2026 ASCO GU Cancers Symposium.
Charles B. Nguyen, MD, is a genitourinary medical oncolgoist at City of Hope Orange County in Irvine, California.

Final overall survival data for PEACE-3 (NCT02194842) evaluating the combination of enzalutamide (Xtandi) and radium-223 (Xofigo) will be presented at the 2026 ASCO GU Cancers Symposium.

Explore the latest advancements in muscle-invasive bladder cancer treatment, including immunotherapy and novel therapies enhancing patient outcomes.

Explore the complexities of non-clear cell renal cell carcinoma, its treatment challenges, and promising immunotherapy advancements for better patient outcomes.

Published: June 23rd 2025 | Updated: June 26th 2025